Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419361
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-14
Brief Title:
68GaGa-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients
Sponsor:
First Affiliated Hospital of Chongqing Medical University
Organization:
First Affiliated Hospital of Chongqing Medical University
Study Overview
Official Title:
68GaGa-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Stimulator of interferon gene STING protein plays a vital role in the immune surveillance of tumor microenvironment Monitoring STING expression in tumors benefits the relevant STING therapy This study will investigate the safety biodistribution and potential usefulness of a novel 68Ga-labeled agonist 68GaGa-Sa-DABI-4 for noninvasive positron emission tomography PET imaging of STING expression in the tumor microenvironment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None